Igor Matushansky

2.3k total citations
48 papers, 1.8k citations indexed

About

Igor Matushansky is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Igor Matushansky has authored 48 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 15 papers in Oncology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Igor Matushansky's work include Epigenetics and DNA Methylation (12 papers), Sarcoma Diagnosis and Treatment (12 papers) and Virus-based gene therapy research (10 papers). Igor Matushansky is often cited by papers focused on Epigenetics and DNA Methylation (12 papers), Sarcoma Diagnosis and Treatment (12 papers) and Virus-based gene therapy research (10 papers). Igor Matushansky collaborates with scholars based in United States, Switzerland and Australia. Igor Matushansky's co-authors include Sara Siddiqi, Arthur I. Skoultchi, Carlos Cordon‐Cardo, Farshid Radparvar, Joslyn Mills, Elizabeth Charytonowicz, Filemon S. Dela Cruz, Robert G. Maki, Eva Hernando and Nicholas D. Socci and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Igor Matushansky

47 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Igor Matushansky United States 21 1.1k 593 576 313 150 48 1.8k
Daniel Wai United States 22 945 0.8× 514 0.9× 616 1.1× 362 1.2× 182 1.2× 42 1.7k
Markus Heidenblad Sweden 14 1.1k 0.9× 332 0.6× 261 0.5× 655 2.1× 92 0.6× 19 1.7k
Nadem Soufir France 22 877 0.8× 649 1.1× 231 0.4× 323 1.0× 109 0.7× 47 1.7k
Deqin Ma United States 21 825 0.7× 196 0.3× 249 0.4× 217 0.7× 40 0.3× 46 1.4k
Abha Khanna United States 12 764 0.7× 761 1.3× 352 0.6× 402 1.3× 54 0.4× 28 1.8k
Albert J.W. Zendman Netherlands 21 1.0k 0.9× 528 0.9× 230 0.4× 412 1.3× 98 0.7× 26 2.8k
P Cairns United States 17 1.7k 1.5× 599 1.0× 629 1.1× 536 1.7× 69 0.5× 18 2.5k
David Cappellen France 21 1.6k 1.4× 545 0.9× 177 0.3× 277 0.9× 68 0.5× 50 2.3k
Juan Saus Spain 22 754 0.7× 213 0.4× 256 0.4× 385 1.2× 60 0.4× 40 1.9k
Stine H. Kresse Norway 21 877 0.8× 350 0.6× 443 0.8× 604 1.9× 27 0.2× 30 1.5k

Countries citing papers authored by Igor Matushansky

Since Specialization
Citations

This map shows the geographic impact of Igor Matushansky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Matushansky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Matushansky more than expected).

Fields of papers citing papers by Igor Matushansky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Igor Matushansky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Matushansky. The network helps show where Igor Matushansky may publish in the future.

Co-authorship network of co-authors of Igor Matushansky

This figure shows the co-authorship network connecting the top 25 collaborators of Igor Matushansky. A scholar is included among the top collaborators of Igor Matushansky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Igor Matushansky. Igor Matushansky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lauterbach, Henning, Sarah Schmidt, Xiaoping Qing, et al.. (2021). Development and Characterization of a Novel Non-Lytic Cancer Immunotherapy Using a Recombinant Arenavirus Vector Platform. Frontiers in Oncology. 11. 732166–732166. 15 indexed citations
2.
Ho, Alan L., Marshall R. Posner, Jiaxin Niu, et al.. (2021). First report of the safety/tolerability and preliminary antitumor activity of HB-201 and HB-202, an arenavirus-based cancer immunotherapy, in patients with HPV16+ cancers.. Journal of Clinical Oncology. 39(15_suppl). 2502–2502. 5 indexed citations
3.
Matushansky, Igor, Filemon S. Dela Cruz, Beverly J. Insel, Dawn L. Hershman, & Alfred I. Neugut. (2013). Chemotherapy Use in Elderly Patients with Soft Tissue Sarcoma: A Population-based Study. Cancer Investigation. 31(2). 83–91. 7 indexed citations
4.
Charytonowicz, Elizabeth, Igor Matushansky, Mireia Castillo-Martín, et al.. (2012). PAX7-FKHR fusion gene inhibits myogenic differentiation via NF-kappaB upregulation. Clinical & Translational Oncology. 14(3). 197–206. 14 indexed citations
5.
Siddiqi, Sara, et al.. (2012). Hiwi Mediated Tumorigenesis Is Associated with DNA Hypermethylation. PLoS ONE. 7(3). e33711–e33711. 66 indexed citations
6.
Cruz, Filemon S. Dela, et al.. (2012). A transgenic, mesodermal specific, Dkk1 mouse model recapitulates a spectrum of human congenital limb reduction defects. Differentiation. 83(4). 220–230. 5 indexed citations
7.
Zhang, Xiao, Felix de la Cruz, Mary Beth Terry, Fabrizio Remotti, & Igor Matushansky. (2012). Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming. Oncogene. 32(18). 2249–2260. 109 indexed citations
8.
Charytonowicz, Elizabeth, et al.. (2012). PPARγ agonists enhance ET-743–induced adipogenic differentiation in a transgenic mouse model of myxoid round cell liposarcoma. Journal of Clinical Investigation. 122(3). 886–898. 50 indexed citations
9.
Mills, Joslyn, Todd Hricik, Sara Siddiqi, & Igor Matushansky. (2011). Chromatin Structure Predicts Epigenetic Therapy Responsiveness in Sarcoma. Molecular Cancer Therapeutics. 10(2). 313–324. 10 indexed citations
10.
Matushansky, Igor & Robert N. Taub. (2011). Adjuvant chemotherapy in 2011 for patients with soft-tissue sarcoma. Nature Reviews Clinical Oncology. 8(7). 434–438. 9 indexed citations
11.
Siddiqi, Sara, Joslyn Mills, & Igor Matushansky. (2010). Epigenetic Remodeling of Chromatin Architecture: Exploring Tumor Differentiation Therapies in Mesenchymal Stem Cells and Sarcomas. Current Stem Cell Research & Therapy. 5(1). 63–73. 34 indexed citations
12.
Mills, Joslyn, Tulio Matos, Elizabeth Charytonowicz, et al.. (2009). Characterization and comparison of the properties of sarcoma cell linesin vitroandin vivo. Human Cell. 22(4). 85–93. 19 indexed citations
13.
Matushansky, Igor, et al.. (2009). MFH classification: differentiating undifferentiated pleomorphic sarcoma in the 21st Century. Expert Review of Anticancer Therapy. 9(8). 1135–1144. 109 indexed citations
14.
Matushansky, Igor, Eva Hernando, Nicholas D. Socci, et al.. (2008). A Developmental Model of Sarcomagenesis Defines a Differentiation-Based Classification for Liposarcomas. American Journal Of Pathology. 172(4). 1069–1080. 66 indexed citations
15.
Charytonowicz, Elizabeth, Carlos Cordon‐Cardo, Igor Matushansky, & Mel Ziman. (2008). Alveolar rhabdomyosarcoma: Is the cell of origin a mesenchymal stem cell?. Cancer Letters. 279(2). 126–136. 109 indexed citations
16.
Hernando, Eva, Elizabeth Charytonowicz, Mária Dudás, et al.. (2007). The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas. Nature Medicine. 13(6). 748–753. 218 indexed citations
17.
Matushansky, Igor, Eva Hernando, Nicholas D. Socci, et al.. (2007). Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway. Journal of Clinical Investigation. 117(11). 3248–3257. 152 indexed citations
18.
Matushansky, Igor & Robert G. Maki. (2005). Mechanisms of Sarcomagenesis. Hematology/Oncology Clinics of North America. 19(3). 427–449. 19 indexed citations
19.
Rekhtman, Natasha, Kevin S. Choe, Igor Matushansky, et al.. (2003). PU.1 and pRB Interact and Cooperate To Repress GATA-1 and Block Erythroid Differentiation. Molecular and Cellular Biology. 23(21). 7460–7474. 85 indexed citations
20.
Matushansky, Igor. (2000). Reprogramming erythroleuekmia cells to terminal differentiation and terminal cell division. Frontiers in bioscience. 5(1). d488–d488. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Wai Breakdown of academic impact, for papers by Markus Heidenblad Breakdown of academic impact, for papers by Nadem Soufir Breakdown of academic impact, for papers by Deqin Ma Breakdown of academic impact, for papers by Abha Khanna Breakdown of academic impact, for papers by Albert J.W. Zendman Breakdown of academic impact, for papers by P Cairns Breakdown of academic impact, for papers by David Cappellen Breakdown of academic impact, for papers by Juan Saus Breakdown of academic impact, for papers by Stine H. Kresse
Rankless by CCL
2026